ProShares Ultra Nasdaq Biotechnology
NasdaqGM · USDThe index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Be the first to share your outlook and start the conversation with other investors in the BIB community.